Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Dr. Martens Plc ( (GB:DOCS) ) has issued an update.
Dr. Martens Plc has announced transactions involving the acquisition of shares by its directors under the company’s Share Incentive Plan (SIP), a scheme allowing employees to purchase shares and receive matching shares. Directors Ije Nwokorie and Giles Wilson each acquired 222 partnership shares at 67.50 pence per share and were allocated an equal number of matching shares. This move, conducted on the London Stock Exchange, is part of the company’s efforts to align employee and stakeholder interests through equity participation.
More about Dr. Martens Plc
Dr. Martens Plc operates in the fashion industry, primarily known for designing and manufacturing iconic footwear, particularly boots. The company focuses on a diverse market, catering to both fashion-conscious consumers and those seeking durable, comfortable footwear.
YTD Price Performance: -9.14%
Average Trading Volume: 2,031,985
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £632.2M
See more data about DOCS stock on TipRanks’ Stock Analysis page.